课题基金 / 基金详情

Neurobiology of mouse models for human chr 16p11.2 microdeletion and fragile x

Neurobiology of mouse models for human chr 16p11.2 microdeletion and fragile x
人类 chr 16p11.2 微缺失和脆性 x 小鼠模型的神经生物学
批准号:
8047959
负责人:
Mark F Bear
金额:
$24.95万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-18 至 2012-02-29

项目摘要

项目成果

Mark F Bear的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autism is a pervasive developmental disorder characterized by impairment in social interaction and communication, and restricted repetitive and stereotyped behavior or interest. Fragile X syndrome and autism have overlapping clinical presentation, thus may share common biochemical and neurophysiological features. Identifying these commonalities is vital in understanding the pathogenesis and providing effective therapies for both neurodevelopmental disorders. Human chromosome 16p11.2 microdeletion is the most common chromosome copy number variation (CNV) in autism. We plan to generate mice carrying deletion of a syntenic region to model human chr16p11.2 microdeletion phenotypes. We hypothesize that deletion at human chr16p11.2 causes synaptic pathophysiology that overlaps with Fragile X syndrome. This hypothesis will be tested in a battery of experiments that have been successfully conducted in Fragile X mice in our laboratory. PUBLIC HEALTH RELEVANCE: Autism and Fragile X syndrome are major public health concerns which share some common features in both clinical presentations and pathogenesis. Identifying and characterizing these features is vital in developing effective therapies for both diseases. This can be accomplished by comparing animal models for autism and Fragile X syndrome.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.neuron.2012.03.009
发表时间: 2012-04-12
期刊: Neuron
影响因子: 16.2
作者: [Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, Bear MF, Lindemann L]
通讯作者: Lindemann L
Pathophysiology and treatment of fragile X and related disorders
Pathophysiology and treatment of fragile X and related disorders
Using the principles of synaptic plasticity to promote recovery from amblyopia
Using the principles of synaptic plasticity to promote recovery from amblyopia
海外基金